Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo

Kate Vandyke, Melanie Y. White, Terry Nguyen-Khuong, Kim Ow, Sharon C.W. Luk, Elizabeth A. Kingsley, Alexandra Rowe, Shiu Fun Pang, Bradley J. Walsh, Pamela J. Russell

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Few treatment options exist for metastatic prostate cancer (PC) that becomes hormone refractory (HRPC). In vitro, plant-derived MINA-05 caused dose-dependent decreases in cell numbers in HRPC cell lines LNCaPC4-2B and PC-3, and in androgen-sensitive LNCaP-FGC, DuCaP, and LAPC-4, by WST-1 assay. MINA-05 pretreatment significantly decreased clonogenic survival in agar and on plastic at 1 x and 2 x IC50 for PC-3 (P < .05 and P < .001, respectively), and at 1/2 x, 1 x, and 2 x IC50 for LNCaP-FGC cells (P < .001). MINA-05 also induced G2M arrest of LNCaP-FGC and PC-3 cells (by flow cytometry) and caused some apoptosis in LNCaP-FGC (sub-G 1 peak on flow, expression of activated caspase-3) but not in PC-3 cells. Western blotting indicated that these cell cycle changes were associated with decreased levels of regulatory proteins cyclin B1 and cdc25C. MINA-05 given daily by gavage for 39 days did not diminish primary orthotopic PC-3 growth in nude mice, but decreased the extent of lymph node invasion at higher doses. We conclude that MINA-05 induces G2M arrest, inhibits cell growth, reduces PC cell regrowth in vitro, and reduces lymph node invasion after orthotopic PC-3 cell implantation in vivo. It has potential as an adjuvant treatment for patients with PC.

LanguageEnglish
Pages322-331
Number of pages10
JournalNeoplasia
Volume9
Issue number4
DOIs
Publication statusPublished - 1 Jan 2007

Keywords

  • Clonogenic assays
  • GM block
  • Lymph node metastases
  • MINA-05 herbal treatment
  • Prostate cancer

ASJC Scopus subject areas

  • Cancer Research

Cite this

Vandyke, K., White, M. Y., Nguyen-Khuong, T., Ow, K., Luk, S. C. W., Kingsley, E. A., ... Russell, P. J. (2007). Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo. Neoplasia, 9(4), 322-331. https://doi.org/10.1593/neo.06775
Vandyke, Kate ; White, Melanie Y. ; Nguyen-Khuong, Terry ; Ow, Kim ; Luk, Sharon C.W. ; Kingsley, Elizabeth A. ; Rowe, Alexandra ; Pang, Shiu Fun ; Walsh, Bradley J. ; Russell, Pamela J. / Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo. In: Neoplasia. 2007 ; Vol. 9, No. 4. pp. 322-331.
@article{675103d2ee9a48cfaf026f8cc6aaba33,
title = "Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo",
abstract = "Few treatment options exist for metastatic prostate cancer (PC) that becomes hormone refractory (HRPC). In vitro, plant-derived MINA-05 caused dose-dependent decreases in cell numbers in HRPC cell lines LNCaPC4-2B and PC-3, and in androgen-sensitive LNCaP-FGC, DuCaP, and LAPC-4, by WST-1 assay. MINA-05 pretreatment significantly decreased clonogenic survival in agar and on plastic at 1 x and 2 x IC50 for PC-3 (P < .05 and P < .001, respectively), and at 1/2 x, 1 x, and 2 x IC50 for LNCaP-FGC cells (P < .001). MINA-05 also induced G2M arrest of LNCaP-FGC and PC-3 cells (by flow cytometry) and caused some apoptosis in LNCaP-FGC (sub-G 1 peak on flow, expression of activated caspase-3) but not in PC-3 cells. Western blotting indicated that these cell cycle changes were associated with decreased levels of regulatory proteins cyclin B1 and cdc25C. MINA-05 given daily by gavage for 39 days did not diminish primary orthotopic PC-3 growth in nude mice, but decreased the extent of lymph node invasion at higher doses. We conclude that MINA-05 induces G2M arrest, inhibits cell growth, reduces PC cell regrowth in vitro, and reduces lymph node invasion after orthotopic PC-3 cell implantation in vivo. It has potential as an adjuvant treatment for patients with PC.",
keywords = "Clonogenic assays, GM block, Lymph node metastases, MINA-05 herbal treatment, Prostate cancer",
author = "Kate Vandyke and White, {Melanie Y.} and Terry Nguyen-Khuong and Kim Ow and Luk, {Sharon C.W.} and Kingsley, {Elizabeth A.} and Alexandra Rowe and Pang, {Shiu Fun} and Walsh, {Bradley J.} and Russell, {Pamela J.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1593/neo.06775",
language = "English",
volume = "9",
pages = "322--331",
journal = "Neoplasia (New York, N.Y.)",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "4",

}

Vandyke, K, White, MY, Nguyen-Khuong, T, Ow, K, Luk, SCW, Kingsley, EA, Rowe, A, Pang, SF, Walsh, BJ & Russell, PJ 2007, 'Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo', Neoplasia, vol. 9, no. 4, pp. 322-331. https://doi.org/10.1593/neo.06775

Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo. / Vandyke, Kate; White, Melanie Y.; Nguyen-Khuong, Terry; Ow, Kim; Luk, Sharon C.W.; Kingsley, Elizabeth A.; Rowe, Alexandra; Pang, Shiu Fun; Walsh, Bradley J.; Russell, Pamela J.

In: Neoplasia, Vol. 9, No. 4, 01.01.2007, p. 322-331.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo

AU - Vandyke, Kate

AU - White, Melanie Y.

AU - Nguyen-Khuong, Terry

AU - Ow, Kim

AU - Luk, Sharon C.W.

AU - Kingsley, Elizabeth A.

AU - Rowe, Alexandra

AU - Pang, Shiu Fun

AU - Walsh, Bradley J.

AU - Russell, Pamela J.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Few treatment options exist for metastatic prostate cancer (PC) that becomes hormone refractory (HRPC). In vitro, plant-derived MINA-05 caused dose-dependent decreases in cell numbers in HRPC cell lines LNCaPC4-2B and PC-3, and in androgen-sensitive LNCaP-FGC, DuCaP, and LAPC-4, by WST-1 assay. MINA-05 pretreatment significantly decreased clonogenic survival in agar and on plastic at 1 x and 2 x IC50 for PC-3 (P < .05 and P < .001, respectively), and at 1/2 x, 1 x, and 2 x IC50 for LNCaP-FGC cells (P < .001). MINA-05 also induced G2M arrest of LNCaP-FGC and PC-3 cells (by flow cytometry) and caused some apoptosis in LNCaP-FGC (sub-G 1 peak on flow, expression of activated caspase-3) but not in PC-3 cells. Western blotting indicated that these cell cycle changes were associated with decreased levels of regulatory proteins cyclin B1 and cdc25C. MINA-05 given daily by gavage for 39 days did not diminish primary orthotopic PC-3 growth in nude mice, but decreased the extent of lymph node invasion at higher doses. We conclude that MINA-05 induces G2M arrest, inhibits cell growth, reduces PC cell regrowth in vitro, and reduces lymph node invasion after orthotopic PC-3 cell implantation in vivo. It has potential as an adjuvant treatment for patients with PC.

AB - Few treatment options exist for metastatic prostate cancer (PC) that becomes hormone refractory (HRPC). In vitro, plant-derived MINA-05 caused dose-dependent decreases in cell numbers in HRPC cell lines LNCaPC4-2B and PC-3, and in androgen-sensitive LNCaP-FGC, DuCaP, and LAPC-4, by WST-1 assay. MINA-05 pretreatment significantly decreased clonogenic survival in agar and on plastic at 1 x and 2 x IC50 for PC-3 (P < .05 and P < .001, respectively), and at 1/2 x, 1 x, and 2 x IC50 for LNCaP-FGC cells (P < .001). MINA-05 also induced G2M arrest of LNCaP-FGC and PC-3 cells (by flow cytometry) and caused some apoptosis in LNCaP-FGC (sub-G 1 peak on flow, expression of activated caspase-3) but not in PC-3 cells. Western blotting indicated that these cell cycle changes were associated with decreased levels of regulatory proteins cyclin B1 and cdc25C. MINA-05 given daily by gavage for 39 days did not diminish primary orthotopic PC-3 growth in nude mice, but decreased the extent of lymph node invasion at higher doses. We conclude that MINA-05 induces G2M arrest, inhibits cell growth, reduces PC cell regrowth in vitro, and reduces lymph node invasion after orthotopic PC-3 cell implantation in vivo. It has potential as an adjuvant treatment for patients with PC.

KW - Clonogenic assays

KW - GM block

KW - Lymph node metastases

KW - MINA-05 herbal treatment

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=34247249279&partnerID=8YFLogxK

U2 - 10.1593/neo.06775

DO - 10.1593/neo.06775

M3 - Article

VL - 9

SP - 322

EP - 331

JO - Neoplasia (New York, N.Y.)

T2 - Neoplasia (New York, N.Y.)

JF - Neoplasia (New York, N.Y.)

SN - 1522-8002

IS - 4

ER -